Publications by authors named "Hege Russnes"

Claim this Profile
M
Microcosting Study of Genomic Profiling for Precision Cancer Medicine: Application from the National Infrastructure for Precision Diagnostics in Norway.
Pia S Henkel, Eline Aas, Hege G Russnes, Ingrid Dyvik, G Live Fagereng

J Mol Diagn· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Lars Asphaug, Lars A Akslen, Egil S Blix, Beate Boge, Elin F Borgen, Hege E G Russnes

Clin Breast Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Hege G Russnes

Mol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.
Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin, Anne-Sofie F Rise, Alberto J Arribas, Hege G Russnes

Cell Death Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.
Andreas Hagen Røssevold, Xavier Tekpli, Ole Christian Lingjærde, Hege G Russnes, Johan Vallon-Christersson

Commun Med (Lond)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.
Marit Otterlei Fjørtoft, Øystein Garred, Ole Christian Lingjærde, Karin Teien Lande, Lars Ottestad, Hege Russnes

BJC Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3.
Qian Wei, Håvard Foyn, Johannes Landskron, Shixiong Wang, Inga Hansine Rye, Hege Elisabeth Giercksky Russnes

iScience· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
Anders Edsjö, Hege G Russnes, Janne Lehtiö, David Tamborero, Eivind Hovig

J Intern Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 - merging clinical research and standard healthcare.
Elisa Bjørgo, Gro L Fagereng, Hege G Russnes, Sigbjørn Smeland, Kjetil Taskén

Acta Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Kjetil Taskén, Soemeya F Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Hege G Russnes

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implications.
Pitt Niehusmann, Henning Leske, Vigdis Nygaard, Hege G Russnes, Sen Zhao

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Claire Quaghebeur, Bjørnar Gilje, Beate Boge, Hege G Russnes

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Raising the quality of cancer treatment].
Åslaug Helland, Eli Sihn Samdal Steinskog, Egil Støre Blix, Åsmund Flobak, Sigmund Brabrand, Hege G Russnes

Tidsskr Nor Laegeforen· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Hilde K Gjelberg, Lars Helgeland, Knut Liseth, Francesca Micci, Miriam Sandnes, Hege G Russnes

Curr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.
Connor Stashko, Mary-Kate Hayward, Jason J Northey, Neil Pearson, Alastair J Ironside, Hege G Russnes

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Andreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Annette Bjerre, Bjørnar Gilje, Erik Hugger Jakobsen, Hege Giercksky Russnes

Nat Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models.
Åsmund Flobak, Sigrid S Skånland, Eivind Hovig, Kjetil Taskén, Hege G Russnes

Trends Pharmacol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial genomics maps the structure, nature and evolution of cancer clones.
Artem Lomakin, Jessica Svedlund, Carina Strell, Milana Gataric, Artem Shmatko, Hege Russnes

Nature· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.
Esmaeil Dorraji, Elin Borgen, Dario Segura-Peña, Puneet Rawat, Eva Smorodina, Hege Russnes

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer - the MetAction precision medicine study.
Anne Hansen Ree, Gunhild M Mælandsmo, Kjersti Flatmark, Hege G Russnes, Mónica Gómez Castañeda

Acta Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.
Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H Saal, Siker Kimbung, Hege Russnes

NPJ Breast Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
Åslaug Helland, Hege G Russnes, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson

J Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national precision cancer medicine implementation initiative for Norway.
Kjetil Taskén, Hege E G Russnes, Eline Aas, Line Bjørge, Egil S Blix

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
Åslaug Helland, Hege G Russnes, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson

J Transl Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.
Margherita Ambrosini, Marzia Del Re, Paolo Manca, Andrew Hendifar, Alexander Drilon, Hege G Russnes

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis